What qualifies as a live embryo?
What qualifies as a live embryo?
复制标题
什么才算是活胚胎?
DOI:
10.1080/15265160500318795
复制
发表时间:
2005
期刊:
影响因子:
--
通讯作者:
Wasserman,David
中科院分区:
文献类型:
--
作者:
Wasserman,David
S. Matthew Liao (2005) argues that the Blastocyst Transfer Method will be less objectionable to conservative opponents of stem-cell research than several of its rivals: using parthenogenesis to make oocytes into embryos that are not capable of complete gestation, harvesting stem cells from “dead” embryos, and creating a “pseudo-embryo” without the capacity to form a placenta or gestate. Liao sees these alternatives as failing to provide adequate assurance to “embryoists”—those who believe in the personhood of embryos—that a live embryo is not being destroyed in obtaining stem cells. In the first case,“it seems likely that it is only a matter of time before normal-developing human beings can be created via parthenogenesis. Perhaps the present technique is causing these embryos not to be able to develop into full term human beings”(11). In the case of “dead” embryos, there may be ways to jump-start embryos that have arrested cell division, much like a defibrillator can be used to jump start an individual with cardiac arrest. If so, an arrest in cell division does not necessarily mean the embryo is dead”(11). And it may be possible to turn on the inactive development genes in pseudo-embryos, making them into the real thing (11). It seems, however, that a similar claim could be made about the pluripotent cells Liao proposes harvesting from 5–7 day-old embryos: although these cells cannot at present develop into human beings, there may soon be ways of restoring that potential, lost just days earlier. If extracted stems cells could be made totipotent, those cells, like the entities subjected to an “improved” process of parthenogenesis, revived “dead” embryos, and pseudo-embryos that had their gestational genes turned on, would all qualify as live embryos and would be, for the embryoist, persons. While the extraction of stem cells by the blastocyst transfer method might not be morally problematic, since it would preserve the embryo while establishing the separate identity of the extracted cell, that cell, once made totipotent, could not be subject to experimentation any more than the embryo from which it was extracted. The embryoist’s objection, though, as Liao represents it, appears to be even stronger. The proposed stem-cell sources should be regarded as live embryos just because they could be made totipotent by a future technology, so that, even untransformed, they should not be destroyed to harvest stem cells. But wouldn’t this also mean that no stem cell, however extracted, could be subject to dangerous experimentation, because stem cells could also be made totipotent? Moreover, since cloning techniques may soon be able to make any somatic cell totipotient, shouldn’t each of those cells now be regarded as a live embryo, precluding hygiene and grooming, let alone medical intervention? Liao, or the embryoists whose objections he anticipates, might respond that it is not the mere technological possibility of making a cell totipotent that gives it the status of a live embryo. There are at least two other related conditions the embryoist could impose that might distinguish oocyctes subject to “unimproved” partheogensis (which I will call “parthoocytes”), pseudo-embryos, and “dead” embryos from normal stem and somatic cells. First, the former but not the latter could be made totipotent without losing identity—they could become totipotent cells, rather